Bloomberg BusinessweekBloomberg Businessweek

Travel Rebound Hindered by Delta Variant

View descriptionShare
 

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the use of the drug ivermectin to treat Covid-19. Bloomberg Businessweek Editor Joel Weber shares stories from the new issue of Businessweek Magazine. Axel Hefer, CEO at Trivago, talks about the company's earnings and how new global virus cases are impacting the travel industry. And we Drive to the Close with Jay Hatfield, CEO at Infrastructure Capital Advisors.

Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Businessweek

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and  
Social links
Follow podcast
Recent clips
Browse 5,281 clip(s)